250 related articles for article (PubMed ID: 27895119)
1. Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.
Corbisier J; Huszagh A; Galés C; Parmentier M; Springael JY
J Biol Chem; 2017 Jan; 292(2):575-584. PubMed ID: 27895119
[TBL] [Abstract][Full Text] [Related]
2. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.
Alvarez Arias D; Navenot JM; Zhang WB; Broach J; Peiper SC
J Biol Chem; 2003 Sep; 278(38):36513-21. PubMed ID: 12837756
[TBL] [Abstract][Full Text] [Related]
4. Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.
Thiele S; Steen A; Jensen PC; Mokrosinski J; Frimurer TM; Rosenkilde MM
J Biol Chem; 2011 Oct; 286(43):37543-54. PubMed ID: 21878623
[TBL] [Abstract][Full Text] [Related]
5. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
[TBL] [Abstract][Full Text] [Related]
6. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
7. Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7.
Steen A; Thiele S; Guo D; Hansen LS; Frimurer TM; Rosenkilde MM
J Biol Chem; 2013 May; 288(18):12511-21. PubMed ID: 23493400
[TBL] [Abstract][Full Text] [Related]
8. Identification of a binding element for the cytoplasmic regulator FROUNT in the membrane-proximal C-terminal region of chemokine receptors CCR2 and CCR5.
Toda E; Terashima Y; Esaki K; Yoshinaga S; Sugihara M; Kofuku Y; Shimada I; Suwa M; Kanegasaki S; Terasawa H; Matsushima K
Biochem J; 2014 Jan; 457(2):313-22. PubMed ID: 24128342
[TBL] [Abstract][Full Text] [Related]
9. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
10. Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes.
Nomiyama H; Hieshima K; Nakayama T; Sakaguchi T; Fujisawa R; Tanase S; Nishiura H; Matsuno K; Takamori H; Tabira Y; Yamamoto T; Miura R; Yoshie O
Int Immunol; 2001 Aug; 13(8):1021-9. PubMed ID: 11470772
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
[TBL] [Abstract][Full Text] [Related]
12. Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
Kothandan G; Gadhe CG; Cho SJ
PLoS One; 2012; 7(3):e32864. PubMed ID: 22479344
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.
Lagane B; Ballet S; Planchenault T; Balabanian K; Le Poul E; Blanpain C; Percherancier Y; Staropoli I; Vassart G; Oppermann M; Parmentier M; Bachelerie F
Mol Pharmacol; 2005 Jun; 67(6):1966-76. PubMed ID: 15761117
[TBL] [Abstract][Full Text] [Related]
14. Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2.
Zweemer AJ; Bunnik J; Veenhuizen M; Miraglia F; Lenselink EB; Vilums M; de Vries H; Gibert A; Thiele S; Rosenkilde MM; IJzerman AP; Heitman LH
Mol Pharmacol; 2014 Oct; 86(4):358-68. PubMed ID: 25024169
[TBL] [Abstract][Full Text] [Related]
15. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.
Liu W; Liu D; Zheng J; Shi P; Chou PH; Oh C; Chen D; An HS; Chee A
Spine J; 2017 May; 17(5):720-726. PubMed ID: 28108404
[TBL] [Abstract][Full Text] [Related]
16. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
17. The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
Pevida M; Lastra A; Meana Á; Hidalgo A; Baamonde A; Menéndez L
Neuroscience; 2014 Feb; 259():113-25. PubMed ID: 24316469
[TBL] [Abstract][Full Text] [Related]
18. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
19. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization.
Zhao J; Ma L; Wu YL; Wang P; Hu W; Pei G
J Cell Biochem; 1998 Oct; 71(1):36-45. PubMed ID: 9736452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
